RecruitingPhase 1NCT07372989

Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Maule Stem Cell Research Institute, Inc.
Principal Investigator
Cynthia S. Maule, M.D., MD
Maule Stem Cell Research Institute
Intervention
Matrix(biological)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
20262028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07372989 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials